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pH-sensitiveLipidic amphiphiles equipped with the trans-2-aminocyclohexanol (TACH) moiety are promising pH-sensitive
conformational switches (“ﬂipids”) that can trigger a lipid bilayer perturbation in response to increased acidity.
Because pH-sensitivity was shown to improve the efﬁciency of several gene delivery systems, we expected that
such ﬂipids could signiﬁcantly enhance the gene transfection by lipoplexes. Thus a series of novel lipids with var-
ious TACH-based head groups and hydrocarbon tails were designed, prepared and incorporated into lipoplexes
that contain the cationic lipid 1,2-dioleoyl-3-trimethylammonio-propane (DOTAP) and plasmid DNA encoding
a luciferase gene. B16F1 and HeLa cells were transfected with such lipoplexes in both serum-free and serum-
containing media. The lipoplexes consisting of TACH-lipids exhibited up to two orders of magnitude better
transfection efﬁciency and yet similar toxicity compared to the ones with the conventional helper lipids 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) or cholesterol. Thus, the TACH-lipids can be used as novel
helper lipids for efﬁcient gene transfection with low cytotoxicity.
© 2015 Published by Elsevier B.V.1. Introduction
The development of genedelivery systemsof high efﬁciency and low
toxicity continues to drawmuch attention because of their critical appli-
cations in modern medicine, including gene therapy in the clinic and
basic research using transgenic cell lines and animals. Since their incep-
tion in 1987 [1], the cationic liposome/DNA complexes (lipoplexes)
have become one of the most commonly used non-viral gene delivery
systems. Cationic lipoplexes have several advantages over viral gene
delivery systems, including convenience in preparation, high capacity,
virtually unlimited cargo gene size and lower toxicity. Compared to
polyplexes, which are another major non-viral gene delivery system,
the lipoplexes are less immunogenic. However, the main drawback of
lipoplexes is their relatively low efﬁciency compared to viral gene
vectors [2].lbecco's Modiﬁcation of Eagle's
ethanolamine; DOTAP, 1,2-
vine serum; HEPES, 2-[4-(2-
HRMS, high resolution mass
S, phosphate-buffered saline;
aminocyclohexanol.
f Pharmaceutics and Medicinal
lth Sciences, University of the
oshina), xguo@paciﬁc.eduExtensive investigation over the past three decades has established
that lipoplexes deliver genes into cells by a multi-step mechanism.
After administration, cationic lipoplexes ﬁrst adsorb onto the negatively
charged cell surface by electrostatic interaction with anionic heparin
sulfate, which is part of the extracellular matrix [3,4]. The adsorption
causes endocytosis [5] that transfers the lipoplexes ﬁrst into the
endosomes, and then into the lysosomal compartment. While proc-
essed in the endosomal/lysosomal pathway, the cationic lipoplexes ex-
change lipids with the negatively charged endosomal/lysosomal
membranes to destabilize themembranes and to release a small portion
of the cargoDNA from the endosomal/lysosomal compartments into the
cytosol [6,7]. Some of the releasedDNAeventually partition from the cy-
tosol into the nucleus for the transgene expression [8]. However, the
majority of the cargo DNA are degraded in the lysosomal compartment,
which represents amajor barrier that limits the efﬁciency of gene deliv-
ery by lipoplexes [9].
One important feature of the endosomal/lysosomal pathway is the
decrease of pH inside the endosomal and lysosomal compartments
[10]. Such feature is exploited by many viruses to enhance their gene
transfection inside the host cells. For example, a glycoprotein of
the inﬂuenza virus, hemagglutinin fuses the viral membrane with
the endosome membrane in response to the pH drop to transfer
the viral genome from the endosome to the cytosol [11]. pH-
sensitivity has also been exploited to enhance gene transfection
by lipoplexes, such as the incorporation of pH-sensitive peptides/
polymers [12], and the development of pH-sensitive cationic lipids
[13].
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lipoplexes has been to develop cationic lipids of optimized structure.
In this regard, numerous cationic lipids carrying diverse headgroups,
lipid tails, as well as linker groups have been reported, some of which
successfully commercialized as gene transfection agents in biological
and pharmaceutical research [14]. Nevertheless, neutrally charged
“helper lipids” also participate in the formation of lipoplexes and play
an essential role in transformation of lipoplexes to non-bilayer
(inverted hexagonal) phases that more efﬁciently destabilizes the
endosomal/lysosomal membranes and consequently increases the
amount of DNA that can escape the endosomal/lysosomal pathway
[15,16]. Therefore the discovery of novel and effective helper lipids
can be another approach to enhance the gene delivery efﬁciency. To
date, the vast majority of reported gene transfections by lipoplexes
used either 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)
or cholesterol as the helper lipid and only a few other helper lipids
have been studied, including partially ﬂuorinated DOPE analogs [17], a
phosphatidylcholine bearing dodecanedioic acid monobenzyl ester
chains [18], N-lauroylsarcosine [19], and more recently, 1-alkyl-2-acyl
phosphatidylcholines [20]. Furthermore, no pH-sensitive helper lipids
for the lipoplexes have been reported to date.
We recently designed a novel type of amphiphiles based on trans-2-
aminocyclohexanol (TACH) and introduced these TACH-lipids as a pH-
sensitive conformational switch of liposome bilayer [21–24] (Scheme 1).
In the original conformational equilibrium A ⇆ B (Scheme 1), the
amine and the hydroxy groups of TACH-lipid are predominantly in
axial positionswhile both lipidic trans-ester groups adopt equatorial posi-
tions (A). The protonation of the amine nitrogen upon addition of acid
results in a strong intramolecular hydrogen bond between the amine
and the hydroxy groups, forcing both groups to adopt equatorial posi-
tions. This impulse is mechanically transmitted via the conformational
ﬂip of the cyclohexane ring to force both ester groups into axial
positions (BH+ on Scheme 1), thereby drastically increasing the spatial
separation of the lipid tails and perturbing the bilayer structure. After
incorporation into liposome membranes, TACH-lipids signiﬁcantly
enhanced the release from both the traditional liposomes based on
phospholipids and the sterically hindered liposomes containing
mPEG2000-ceramide (PEG-ceramide) upon exposure to lowered pH
[21–24]. To highlight the key role of the conformational ﬂip in the pH-
triggered liposome leakage, we introduced the terms “ﬂipids” for the
amphiphiles containing a pH-sensitive conformational switch and
“ﬂiposomes” for the liposomes comprising these amphiphiles [22–24].
Because pH-sensitivity was shown to improve the efﬁciency of a
number of gene delivery systems, including viral vectors, polyplexes
and lipoplexes [25–27], we postulated that such TACH-derived, pH-
sensitive conformational switches could also serve as helper lipids to
signiﬁcantly enhance the gene transfection by lipoplexes. To explore
this possibility, we prepared a series of novel TACH-lipidswith different
amino groups and lipid tails (1–8 in Fig. 1). The analogous amphiphiles
9 [21,22] and 10 (Fig. 1) were also synthesized as controls that do not
performpH-triggered conformational switch. The commonly used help-
er lipids DOPE and cholesterol were used as pH-insensitive lipids for
comparison. The pH-driven conformational ﬂip of compounds 1–8Scheme 1. Protonation-induced spatial separation and efﬁcient shortening of the TACH-lipid ta
turbation of the lipid bilayer.(Scheme 1) was studied by 1H NMR titration. All the amphiphiles
were incorporated into lipoplexes containing a well-studied cationic
lipid 1,2-dioleoyl-3-trimethylammonio-propane (DOTAP) [28,29] and
plasmid DNA encoding luciferase to mediate gene transfection into
B16F1 and HeLa cancer cells. To the best of our knowledge, this is the
ﬁrst report on pH-sensitive amphiphiles as helper lipids in lipoplexes
for gene delivery.
2. Materials and methods
2.1. Materials
The lipids 1,2-dioleoyl-3-trimethylammonium-propane (chlo-
ride salt) (DOTAP), 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-
ethanolamine (DOPE), and cholesterol were purchased from Avanti
Polar Lipids, Inc. (Alabaster, AL, USA) and usedwithout further puriﬁca-
tion. All other chemicals including 2-[4-(2-hydroxyethyl)piperazin-
1-yl]-ethanesulfonic acid (HEPES) and sodium chloride (NaCl)were pur-
chased from Sigma-Aldrich or Fisher Scientiﬁc. All solvents were puri-
ﬁed by conventional techniques prior to use. Dulbecco's Modiﬁcation
of Eagle's Medium (DMEM), penicillin–streptomycin solution, L-gluta-
mine, trypsin, and phosphate-buffered saline (PBS) were purchased
from Corning Cellgro (Manassas, VA, USA). Fetal bovine serum (FBS)
was purchased from Tissue Culture Biologicals (Tulare, CA, USA). HeLa
cells and B16F1 cells were purchased from American Type Culture Col-
lection (ATCC) (Rockville, MA, USA). pCMV-GLuc Control Plasmid and
BioLux® Gaussia Luciferase Assay Kit were purchased from New
England Biolabs (Hitchin, Hertfordshire, UK).M-PER®Mammalian pro-
tein extraction reagent, Pre-diluted Protein Assay Standards: Bovine
Serum Albumin (BSA) Set and Micro BCA Protein Assay Kit were
purchased from Thermo Scientiﬁc Pierce Protein Biology Products
(Rockford, IL, USA). The 96-well plates were purchased from TPP
(Switzerland).
2.2. Synthesis
The amphiphiles 1–3, 6, and 9, and the corresponding intermediates
were prepared as described earlier [21–24]. Other TACH-lipids (Fig. 1)
were synthesized using similar procedures (Scheme 2). In order to ren-
der “kinks” in the lipid tails of amphiphiles 4 and 8, a cyclopropylmoiety
was introduced into the hydrocarbon chains of the starting unsaturated
alcohol by a diethylzinc-based Simmons–Smith reaction [30] (Scheme
3). 1H NMR and 13C NMR spectra were acquired on a JEOL ECA-600
NMR-spectrometer (600MHz for 1H and 150MHz for 13C). High resolu-
tion mass spectra (HRMS) were obtained on a JEOL AccuTOF time-of-
ﬂight mass spectrometer (Peabody, MA) coupled with an Ionsense
DART open-air ionization source (Saugus, MA).
2.2.1. Dihexadecyl fumarate (11b)
Fumaryl chloride (3.22 g, 20 mmol) was reﬂuxed for 12 h with
1-hexadecanol (10.2 g, 42 mmol) in anhydr. CHCl3 (30 mL). The
reaction mixture was diluted with CHCl3 (60 mL), washed with 5% aq.
NaOH (2 × 20 mL), 5% aqueous HCl (2 × 20 mL), and brine (10 mL),ils, and change of the charge, effective size and shape of the polar head cause a quick per-
Fig. 1. Structure of helper lipids under study: pH-sensitive TACH-lipids 1–8; non-switchable TACH analogs 9 and 10; pH-insensitive control lipids DOPE and cholesterol.
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product was puriﬁed by column chromatography (silica gel;
hexane:EtOAc = 80:1) to afford 11b as a white solid (9.1 g, 81%):
Rf: 0.33 (hexane:EtOAc = 60:1), mp 63.8–64.8 °C. 1H NMR
(600 MHz, CDCl3): δ 0.86 (t, J = 6.9 Hz, 6H, CH3), 1.19–1.37 (m, 52H,Scheme 2. Synthesis of the conformationally switchable amphiphiles 1–8.hexadecyl CH2), 1.65 (quin, J = 6.7 Hz, 4H, hexadecyl CH2), 4.17 (t,
J = 6.7 Hz, 4H, COOCH2), 6.82 (s, 2H, HC_CH). 13C NMR (150 MHz,
CDCl3): δ 14.1 (CH3), 22.7, 25.9, 28.5, 29.21, 29.36, 29.49, 29.56, 29.65,
29.68, 31.9 (CH2), 65.5 (COOCH2), 133.6 (HC_CH), 165.1 (C_O).
HRMS: C36H68O4, calcd.m/z [M+H]+ 565.5196, found 565.5203.
2.2.2. Bis(2-hexyldecyl) fumarate (11c)
Fumaryl chloride (1.61 g, 10 mmol) was reﬂuxed for 12 h with of 2-
hexyl-1-decanol (5.5 g, 22 mmol) in anhydr. chloroform (15 mL). The
reaction mixture was diluted with CHCl3 (30 mL), washed with 5%
aqueous NaOH (2 × 10 mL), 5% aqueous HCl (2 × 5 mL), brine (5 mL),
dried over Na2SO4, and concentrated in vacuo. The crude product was
puriﬁed by column chromatography (silica gel; hexane:EtOAc = 80:1)Scheme 3. Preparation of cis-8-(2-octylcyclopropyl)octan-1-ol 16 for the synthesis of am-
phiphiles 4 and 8.
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40:1). 1H NMR (600 MHz, CDCl3): δ 0.881 (t, J = 7.0 Hz, 6H, CH3),
0.883 (t, J = 7.0 Hz, 6H, CH3), 1.20–1.40 (m, 48H, hexyldecyl CH2),
1.69 (m, 2H, hexyldecyl CH), 4.11 (d, J= 5.7 Hz, 4H, COOCH2), 6.85 (s,
2H, HC_CH). 13C NMR (150 MHz, CDCl3): δ 14.1 (CH3), 22.66, 22.69,
26.67, 26.70, 29.32, 29.57, 29.60, 29.94, 31.21, 31.82, 31.91 (CH2), 37.3
(CH, hexyldecyl), 68.2 (COOCH2), 133.6 (HC_CH), 165.3 (C_O).
HRMS: C36H68O4, calcd. m/z [M+H]+ 565.5196, found 565.5185.
2.2.3. Bis[cis-8-(2-octylcyclopropyl)octyl] fumarate (11d)
Fumaryl chloride (1.41 g, 9.2mmol)was reﬂuxed for 18 hwith cis-8-
(2-octylcyclopropyl)octan-1-ol 16 (5.45 g, 19.3 mmol) in anhydr. chlo-
roform (13 mL). The reaction mixture was diluted with CHCl3 (30 mL),
washed with 5% aqueous NaOH (2 × 10 mL), 5% aqueous HCl
(2 × 15 mL), brine (5 mL), dried over Na2SO4, and concentrated in
vacuo. The crude product was puriﬁed by column chromatography (sil-
ica gel; hexane:EtOAc = 60:1) to afford 11d as a colorless oil (5.16 g,
87%). Rf: 0.20 (hexane:EtOAc = 50:1). 1H NMR (600 MHz, CDCl3):
δ−0.36 (dt, J = 4.3, 5.1 Hz, 2H, trans-H in cyclopropyl CH2), 0.54 (dt,
J= 4.1, 8.2 Hz, 2H, cis-H in cyclopropyl CH2), 0.62 (m, 4H, cyclopropyl
CH), 0.86 (t, J = 7.0 Hz, 6H, CH3), 1.11 (m, 4H, CH2), 1.20–1.39 (m,
48H, CH2), 1.66 (br. quin, J = 7.0 Hz, 4H, CH2), 4.17 (t, J = 6.7 Hz, 4H,
COOCH2), 6.83 (s, 2H, HC_CH). 13C NMR (150 MHz, CDCl3): δ 10.9
(CH2, cyclopropyl), 14.1 (CH3), 15.75 (CH, cyclopropyl), 22.7, 25.9,
28.4, 28.5, 28.7, 29.23, 29.36, 29.55, 29.68, 30.16, 30.21, 31.9 (CH2),
65.5 (OCH2), 133.6 (HC_CH), 165.1 (C_O). HRMS: C42H76O4, calcd.
m/z [M+H]+ 645.5822, found 645.5729.
2.2.4. Dihexadecyl 4-cyclohexene-trans-1,2-dicarboxylate (12b)
Dihexadecyl fumarate 11b (8.8 g, 15.6 mmol), butadiene sulfone
(2.8 g, 23.7 mmol), and hydroquinone (121 mg, 1.1 mmol) were
mixed and diluted with isopropanol (20 mL). The mixture was heated
in a sealed reactor at 120 °C for 48 h. After cooling, water (160 mL)
and CHCl3 (90 mL) were added and the mixture was neutralized with
solid NaHCO3 (35 g). The organic layer was separated, washed with
brine (60 mL) and water (60 mL), dried over MgSO4, and concentrated
in vacuo. The crude product was puriﬁed by column chromatography
(silica gel; hexane:EtOAc = 60:1) to afford 12b as a white solid
(9.24 g, 92%). Rf: 0.36 (hexane:EtOAc = 40:1), mp 40.5–41.5 °C. 1H
NMR (600 MHz, CDCl3): δ 0.86 (t, J = 7.1 Hz, 6H, CH3), 1.19–1.37 (m,
52H, hexadecyl CH2), 1.59 (br. quin, J = 6.8 Hz, 4H, hexadecyl CH2),
2.11–2.21 (m, 2H, H3a+H6a), 2.36–2.46 (m, 2H, H3e+H6e), 2.84 (m,
2H, H1+H2), 4.06 (m, 4H, COOCH2), 5.67 (m, 2H, H4+H5). 13C NMR
(150 MHz, CDCl3): δ 14.1 (CH3), 22.7, 25.8 (CH2), 28.0 (CH2, C6+C3),
28.6, 29.25, 29.35, 29.52, 29.58, 29.68, 31.9 (CH2), 41.3 (CH, C1+C2),
64.8 (COOCH2), 124.96 (CH, C4+C5), 174.9 (C_O). HRMS: C40H74O4,
calcd. m/z [M+H]+ 619.5665, found 619.5644.
2.2.5. Bis(2-hexyldecyl)4-cyclohexene-trans-1,2-dicarboxylate (12c)
Bis(2-hexyldecyl) fumarate 11c (2.24 g, 4 mmol), butadiene sulfone
(0.72 g, 6mmol), andhydroquinone (33mg, 0.3mmol)weremixed and
dilutedwith isopropanol (10mL). Themixturewas heated in the sealed
reactor at 120 °C for 48 h. After cooling, water (60 mL) and CHCl3
(30 mL) were added and the mixture was neutralized with solid
NaHCO3 (9 g). The organic layer was separated, washed with brine
(15 mL) and water (15 mL), dried over MgSO4, and concentrated in
vacuo. The crude product was puriﬁed by column chromatography (sil-
ica gel; hexane:EtOAc= 60:1) to afford 3a as a yellow oil (1.83 g, 74%).
Rf: 0.32 (hexane:EtOAc = 40:1). 1H NMR (600 MHz, CDCl3): δ 0.88 (t,
J = 7.0 Hz, 12H, CH3), 1.20–1.40 (m, 48H, hexyldecyl CH2), 1.62 (m,
2H, hexyldecyl CH), 2.13–2.23 (m, 2H, H3a+H6a), 2.38–2.48 (m, 2H,
H3e+H6e), 2.88 (m, 2H, H1+H2), 3.94 (ddd, J = 10.8, 5.6, 0.6 Hz,
2H, COOCH2), 4.04 (ddd, J = 10.8, 5.8, 0.6 Hz, 2H, COOCH2), 5.69 (m,
2H, H4+H5). 13C NMR (150 MHz, CDCl3): δ 14.1 (CH3), 22.7, 26.69,
26.72 (CH2), 28.0 (CH2, C6+C3), 29.37, 29.62, 29.67, 30.0, 31.17,
31.22, 31.87, 31.94 (CH2), 37.3 (CH, hexyldecyl), 41.3 (CH, C1+C2),67.3 (COOCH2), 125.05 (CH, C4+C5), 174.9 (C_O). HRMS: C40H74O4,
calcd. m/z [M+H]+ 619.5665, found 619.5616.
2.2.6. Bis[cis-8-(2-octylcyclopropyl)octyl]4-cyclohexene-trans-1,2-
dicarboxylate (12d)
Bis(8-(2-octylcyclopropyl)octyl) fumarate 11d (4.26 g, 6.6 mmol),
butadiene sulfone (1.17 g, 9.9 mmol), and hydroquinone (55 mg,
0.5 mmol) were mixed and diluted with isopropanol (25 mL). Themix-
ture was heated in the sealed reactor at 120 °C for 42 h. After cooling,
water (70mL) andCHCl3 (35mL)were added and themixturewasneu-
tralized with solid NaHCO3 (12 g). The organic layer was separated,
washed with brine (20 mL) and water (20 mL), dried over MgSO4, and
concentrated in vacuo. The crude product was puriﬁed by column chro-
matography (silica gel; hexane:EtOAc = 40:1) to afford 12d as a color-
less oil (3.03 g, 66%). Rf: 0.35 (hexane:EtOAc = 30:1). 1H NMR
(600 MHz, CDCl3): δ −0.35 (dt, J = 4.2, 5.3 Hz, 2H, trans-H in
cyclopropyl CH2), 0.55 (dt, J = 4.1, 8.1 Hz, 2H, cis-H in cyclopropyl
CH2), 0.63 (m, 4H, cyclopropyl CH), 0.87 (t, J = 7.0 Hz, 6H, CH3), 1.11
(m, 4H, CH2, octyl), 1.20–1.39 (m, 48H, octyl CH2), 1.60 (br. quin, J =
7.1 Hz, 4H, octyl CH2), 2.12–2.20 (m, 2H, H3a+H6a), 2.35–2.45 (m,
2H, H3e+H6e), 2.83 (m, 2H, H1+H2), 4.05 (m, 4H, COOCH2), 5.66
(m, 2H, H4+H5). 13CNMR (150MHz, CDCl3): δ 11.0 (CH2, cyclopropyl),
14.2 (CH3), 15.8 (CH, cyclopropyl), 22.8, 26.0 (CH2), 28.1 (CH2, C3+C6),
28.69, 28.81, 29.37, 29.46, 29.68, 29.79, 30.3, 32.0 (CH2), 41.4 (CH,
C1+C2), 64.9 (COOCH2), 125.1 (CH, C4+C5), 175.0 (C_O). HRMS:
C46H82O4, calcd.m/z [M+H]+ 699.6291, found 699.6170.
2.2.7. Dihexadecyl 7-oxabicyclo[4.1.0]heptane-trans-3,4-dicarboxylate
(13b)
Dihexadecyl 4-cyclohexene-trans-1,2-dicarboxylate 12b (8.26 g,
13.3 mmol) was dissolved in anhydrous CH2Cl2 (15 mL), and m-CPBA
(4.9 g of 70% tech. grade, 20 mmol) was added in small portions at
0 °C while stirring. The reaction mixture was stirred at 0 °C for 14 h.
After the consumption of the starting material (TLC; silica gel;
hexane:EtOAc = 20:1), chloroform (30 mL) was added followed by
satd. Na2CO3 (40 mL). The mixture was stirred for 30 min and then
the organic phase was washed with satd. Na2CO3 (4 × 20 mL). The or-
ganic layer was dried for 12 h over anhydrous Na2SO4 and then concen-
trated in vacuo. The crude product was puriﬁed by column
chromatography (silica gel; hexane:EtOAc = 12:1) to yield 13b as a
white solid (5.16 g, 61%). Rf: 0.31 (hexane:EtOAc = 8:1), mp 54.0–
55.0 °C. 1H NMR (600 MHz, CDCl3): δ 0.85 (t, J = 7.0 Hz, 6H, CH3),
1.17–1.37 (m, 52H, hexadecyl CH2), 1.57 (m, 4H, hexadecyl CH2), 1.87
(ddd, J = 14.9, 10.8, 2.1 Hz, 1H, H5a), 2.03 (dd, J = 15.5, 10.8 Hz, 1H,
H2a), 2.29 (ddd, J = 15.5, 6.6, 4.8 Hz, 1H, H2e), 2.44 (ddd, J = 14.9,
4.8, 1.8 Hz, 1H, H5e), 2.59 (dt, J = 6.6, 10.7 Hz, 1H, H3), 2.81 (dt, J =
4.9, 10.6 Hz, 1H, H4), 3.16 (t, J = 4.3 Hz, 1H, H1), 3.23 (dt, J = 3.8,
1.9 Hz, 1H, H6), 4.03 (m, 4H, COOCH2). 13C NMR (150 MHz, CDCl3): δ
14.1 (CH3), 22.7, 25.8 (CH2), 26.4 (CH2, C2), 27.2 (CH2, C5), 28.5,
29.24, 29.36, 29.53, 29.59, 29.65, 29.69, 31.9 (CH2), 37.7 (CH, C4), 40.1
(CH, C3), 50.3 (CH, C1), 51.9 (CH, C6), 65.0 (COOCH2), 173.7, 174.7
(C_O). HRMS: C40H74O5, calcd. m/z [M+H]+ 635.5615, found
635.5593.
2.2.8. Bis(2-hexyldecyl)7-oxabicyclo[4.1.0]heptane-trans-3,4-dicarboxylate
(13c)
Bis(2-hexyldecyl) 4-cyclohexene-trans-1,2-dicarboxylate 12c
(0.93 g, 1.5 mmol) was dissolved in 4 mL of dry CH2Cl2, and m-CPBA
(0.74 g of 70% tech. grade, 3 mmol) was added in small portions at
0 °C while stirring. The reaction mixture was stirred at 0 °C for 20 h.
After the consumption of the starting material (TLC; silica gel;
hexane:EtOAc = 30:1), chloroform (4 mL) was added followed by
satd. Na2CO3 (6 mL). The mixture was stirred for 30 min, and then the
organic phase was washed with satd. Na2CO3 (4 × 5 mL). The organic
layer was dried for 12 h over anhydrous Na2SO4 and concentrated in
vacuo. The crude product was puriﬁed by column chromatography
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93%). Rf: 0.20 (hexane:EtOAc = 20:1). 1H NMR (600 MHz, CDCl3): δ
0.88 (t, J = 7.0 Hz, 12H, CH3), 1.20–1.40 (m, 48H, hexyldecyl CH2),
1.61 (m, 2H, hexyldecyl CH), 1.90 (ddd, J = 14.9, 10.5, 2.2 Hz, 1H,
H5a), 2.07 (dd, J = 15.5, 10.6 Hz, 1H, H2a), 2.32 (ddd, J = 15.5, 6.6,
4.7 Hz, 1H, H2e), 2.47 (ddd, J = 14.9, 4.9, 1.7 Hz, 1H, H5e), 2.63 (dt,
J = 6.6, 10.5 Hz, 1H, H3), 2.86 (dt, J = 4.9, 10.4 Hz, 1H, H4), 3.19 (t,
J = 4.2 Hz, 1H, H1), 3.25 (dt, J = 3.7, 1.8 Hz, 1H, H6), 3.93 (ddd, J =
10.8, 5.6, 1.0 Hz, 2H, COOCH2), 4.01 (dt, J = 10.8, 5.8, Hz, 2H,
COOCH2). 13C NMR (150 MHz, CDCl3): δ 14.1 (CH3), 22.7 (CH2), 26.4
(CH2, C2), 26.7 (CH2), 27.2 (CH2, C5), 29.36, 29.61, 29.66, 30.0, 31.15,
31.20, 31.87, 31.94 (CH2), 37.30, 37.32 (CH, hexyldecyl), 37.7 (CH, C4),
40.05 (CH, C3), 50.4 (CH, C1), 51.9 (CH, C6), 67.5 (COOCH2), 173.8,
174.8 (C_O). HRMS: C40H74O5, calcd. m/z [M+H]+ 635.5615, found
635.5583.
2.2.9. Bis[cis-8-(2-octylcyclopropyl)octyl]7-oxabicyclo[4.1.0]heptane-trans-
3,4-dicarboxylate (13d)
Bis[cis-8-(2-octylcyclopropyl)octyl]4-cyclohexene-trans-1,2-
dicarboxylate 12d (2.58 g, 3.7 mmol) was dissolved in anhydr.
CH2Cl2 (5 mL), and m-CPBA (1.36 g of 70% tech. grade, 5.53 mmol)
was added in small portions at 0 °C while stirring. The reaction mix-
ture was stirred at 0 °C for another 18 h. After the consumption of
the starting material (TLC; silica gel; hexane:EtOAc= 20:1), chloroform
(12 mL) was added followed by satd. Na2CO3 (15 mL). The mixture was
stirred for 30 min and then the organic phase was washed with satd.
Na2CO3 (4 × 6mL). The organic layer was dried for 12 h over anhydrous
Na2SO4 and concentrated in vacuo. The crude product was puriﬁed by
column chromatography (silica gel; hexane:EtOAc = 20:1) to yield
13d as a colorless oil (1.64 g, 62%). Rf: 0.24 (hexane:EtOAc = 12:1). 1H
NMR (600 MHz, CDCl3): δ −0.35 (dt, J = 4.2, 5.3 Hz, 2H, trans-H in
cyclopropyl CH2), 0.54 (dt, J = 4.1, 8.2 Hz, 2H, cis-H in cyclopropyl
CH2), 0.63 (m, 4H, cyclopropyl CH), 0.87 (t, J = 7.0 Hz, 6H, CH3), 1.11
(m, 4H, octyl CH2), 1.20–1.39 (m, 48H, octyl CH2), 1.59 (m, 4H, octyl
CH2), 1.88 (ddd, J = 14.9, 10.8, 2.1 Hz, 1H, H5a), 2.04 (dd, J = 15.4,
10.9 Hz, 1H, H2a), 2.30 (ddd, J= 15.5, 6.6, 4.8 Hz, 1H, H2e), 2.45 (ddd,
J = 14.9, 4.9, 1.8 Hz, 1H, H5e), 2.60 (dt, J = 6.7, 10.7 Hz, 1H, H3), 2.82
(dt, J = 4.9, 10.6 Hz, 1H, H4), 3.17 (t, J= 4.3 Hz, 1H, H1), 3.23 (dt, J=
3.7, 1.8 Hz, 1H, H6), 4.04 (m, 4H, COOCH2). 13C NMR (150 MHz,
CDCl3): δ 11.0 (CH2, cyclopropyl), 14.2 (CH3), 15.8 (CH, cyclopropyl),
22.8, 25.95 (CH2), 26.5 (CH2, C2), 27.3 (CH2, C5), 28.64, 28.8, 29.36,
29.45, 29.67, 29.78, 30.27, 30.30, 32.0 (CH2), 37.8 (CH, C4), 40.1 (CH,
C3), 50.4 (CH, C1), 52.0 (CH, C6), 65.0 (COOCH2), 173.8, 174.8 (C_O).
HRMS: C46H82O5, calcd.m/z [M+H]+ 715.6241, found 715.6167.
2.2.10. Bis[cis-8-(2-octylcyclopropyl)octyl]cis-4-hydroxy-trans-5-
morpholinocyclohexane-trans-1,2-dicarboxylate (4)
Bis[cis-8-(2-octylcyclopropyl)octyl] 7-oxabicyclo[4.1.0]heptane-
trans-3,4-dicarboxylate 13d (0.47 g, 0.65 mmol) and morpholine
(0.4 mL, 4.6 mmol) were stirred for 5 days at room temperature in
0.6 mL of i-PrOH:H2O (9:1). The reaction mixture was concentrated
on a rotary evaporator. The crude productwas puriﬁed by column chro-
matography (silica gel; hexane:EtOAc= 9:2) to yield 4 as a colorless oil
(0.44 g, 84%). Rf: 0.23 (hexane:EtOAc = 9:2). 1H NMR (600 MHz,
CD3OD): δ−0.33 (dt, J = 4.1, 5.2 Hz, 2H, trans-H in cyclopropyl CH2),
0.59 (dt, J = 4.1, 8.1 Hz, 2H, cis-H in cyclopropyl CH2), 0.67 (m, 4H,
cyclopropyl CH), 0.90 (t, J = 6.8 Hz, 6H, CH3), 1.19 (m, 4H, octyl CH2),
1.24–1.44 (m, 48H, octyl CH2), 1.62 (br. quin, J = 6.9 Hz, 4H, octyl
CH2), 1.79 (ddd, J = 13.3, 5.0, 4.8 Hz, 1H, H3e), 1.88 (ddd, J = 14.0,
5.3, 3.8 Hz, 1H, H6e), 2.00 (m, 1H, H6a), 2.02 (m, 1H, H3a), 2.24 (dt,
J = 3.0, 5.2 Hz, 1H, H5), 2.50 (m, 2H, CH2N), 2.59 (m, 2H, CH2N), 2.99
(dt, J= 3.5, 9.4 Hz, 1H, H1), 3.09 (dt, J= 4.4, 9.4 Hz, 1H, H2), 3.70 (m,
4H, morpholyl OCH2), 3.99 (dt, J = 2.7, 5.2 Hz, 1H, H4), 4.07 (m, 4H,
COOCH2). 13C NMR (150 MHz, CD3OD): δ 11.6 (CH2, cyclopropyl), 14.5
(CH3), 16.9 (CH, cyclopropyl), 23.8 (CH2), 24.9 (CH2, C6), 27.1, 29.8,
29.9, 30.4, 30.5, 30.7, 30.8, 31.3 (CH2), 31.9 (CH2, C3), 33.1 (CH2),40.68 (CH, C1), 40.77 (CH, C2), 51.5 (NCH2, morpholyl), 65.2 (CH, C5),
65.5 (CH, C4), 65.89, 65.95 (COOCH2), 68.2 (OCH2, morpholyl), 176.1,
176.3 (C_O). HRMS: C50H91NO6, calcd.m/z [M+H]+ 802.6925, found
802.6769.2.2.11. Didodecyl cis-4-hydroxy-trans-5-(2-hydroxyethylamino)cyclohex-
ane-trans-1,2-dicarboxylate (5)
Didodecyl 7-oxabicyclo[4.1.0]heptane-trans-3,4-dicarboxylate 13a
(0.7 g, 1.33 mmol) and 2-aminoethanol (1.6 mL, 26.6 mmol) were
stirred for 72 h at room temperature in 1.1 mL of THF:H2O (10:1). The
reaction mixture was concentrated on the rotary evaporator, and the
crude product was puriﬁed by column chromatography (silica gel;
CHCl3:CH3OH = 15:1) to yield 5 as an ivory solid (0.24 g, 30%). Rf:
0.28 (CHCl3:CH3OH = 10:1), mp 55.0–57.0 °C. 1H NMR (600 MHz,
CDCl3): δ 0.84 (t, J = 6.9 Hz, 6H, CH3), 1.18–1.33 (m, 36H, dodecyl
CH2), 1.47 (ddd, J = 13.4, 8.9, 4.5 Hz, 1H, H6a), 1.58 (m, 4H, dodecyl
CH2), 1.67 (ddd, J = 13.8, 9.0, 4.9 Hz, 1H, H3a), 2.20 (ddd, J = 13.6,
4.8, 3.6 Hz, 1H, H3e), 2.27 (ddd, J = 13.5, 4.8, 3.7 Hz, 1H, H6e), 2.48
(dt, J = 3.5, 8.8 Hz, 1H, H5), 2.64 (ddd, J = 12.2, 6.2, 3.7 Hz, 1H,
CH2N), 2.86 (ddd, J= 12.2, 6.4, 3.6 Hz, 1H, CH2N), 3.10 (q, J = 5.0 Hz,
1H, H1), 3.19 (q, J= 5.0 Hz, 1H, H2), 3.50 (dt, J= 3.7, 8.5 Hz, 1H, H4),
3.61 (ddd, J = 10.8, 6.5, 3.8 Hz, 1H, morpholyl CH2O), 3.65 (ddd, J =
10.9, 6.4, 3.7 Hz, 1H, morpholyl CH2O), 4.05 (m, 4H, COOCH2). 13C
NMR (150 MHz, CDCl3): δ 14.1 (CH3), 22.6, 25.85, 25.89 (CH2), 28.3
(CH2, C6), 28.51, 28.56, 29.2, 29.3, 29.49, 29.56, 29.59 (CH2), 31.3
(CH2, C3), 31.9 (CH2), 40.2 (CH, C1+C2), 48.4 (NCH2), 58.65 (CH, C5),
61.45 (OCH2), 65.13, 65.16 (COOCH2), 69.34 (CH, C4), 173.7, 174.0
(C_O). HRMS: C34H65NO6, calcd. m/z [M+H]+ 584.4890, found
584.4933.2.2.12. Didodecyl cis-4-hydroxy-trans-5-(2,2,2-triﬂuoroethylamino)cyclo-
hexane-trans-1,2-dicarboxylate (7) and didodecyl cis-4-chloro-trans-5-
hydroxycyclohexane-trans-1,2-dicarboxylate (10)
2,2,2-Triﬂuoroethylamine hydrochloride (1.36 g, 10 mmol) was
neutralized by satd. Na2CO3 to pH 7–8 at 0 °C. Didodecyl 7-
oxabicyclo[4.1.0]heptane-trans-3,4-dicarboxylate 13a (0.52 g, 1 mmol)
in iPrOH (1.5 mL) was added, and the mixture was stirred for 7 days
at 40 °C. The reaction mixture was concentrated on the rotary evapora-
tor, and the crudeproductwaspuriﬁed by column chromatography (sil-
ica gel; hexane:EtOAc= 5:1) to yield 7 as a yellowish viscous oil (0.1 g,
16%) and 10 as a white solid (0.38 g, 68% yield). Compound 7: Rf 0.25
(hexane:EtOAc = 5:1). 1H NMR (600 MHz, CD3OD): δ 0.89 (t, J =
6.9 Hz, 6H, CH3), 1.23–1.40 (m, 36H, dodecyl CH2), 1.61 (m, 4H, dodecyl
CH2), 1.78 (dt, J= 13.9, 4.0 Hz, 1H, H6e), 1.82 (dt, J= 13.7, 4.1 Hz, 1H,
H3e), 1.95 (m, 1H, H6a), 1.97 (m, 1H, H3a), 2.79 (q, J=3.8 Hz, 1H, H5),
2.99 (dt, J= 3.7, 9.7 Hz, 1H, H1), 3.03 (dt, J= 4.0, 9.7 Hz, 1H, H2), 3.23
(m, 2H, CH2N), 3.74 (dt, J=3.2, 4.1 Hz, 1H, H4), 4.06 (m, 4H, COOCH2).
13C NMR (150 MHz, CD3OD): δ 14.5 (CH3), 23.8, 27.1 (CH2), 28.8 (CH2,
C6), 29.8, 30.4, 30.5, 30.71, 30.74, 30.79, 30.83 (CH2), 31.45 (CH2, C3),
33.1 (CH2), 40.43 (CH, C1), 40.74 (CH, C2), 48.86 (CH2N), 58.0 (CH,
C5), 65.9 (COOCH2), 68.7 (CH, C4), 128.2 (CF3), 176.5 (C_O). HRMS:
C34H62F3NO5, calcd. m/z [M+H]+ 622.4658, found 622.4647. Com-
pound 10: Rf 0.50 (hexane:EtOAc = 5:1); mp 31.5–32.5 °C. 1H NMR
(600 MHz, CD3OD): δ 0.90 (t, J= 6.9 Hz, 6H, CH3), 1.24–1.40 (m, 36H,
dodecyl CH2), 1.62 (br. quin, J = 7.0 Hz, 4H, dodecyl CH2), 1.92
(ddd, J = 13.9, 3.4, 2.8 Hz, 1H, H6e), 2.04 (m, 1H, H6a), 2.07 (dt,
J = 14.1, 3.1 Hz, 1H, H3e), 2.28 (m, 1H, H3a), 3.03 (m, 2H,
H1+H2), 3.94 (q, J = 3.2 Hz, 1H, H5), 4.07 (m, 4H, COOCH2), 4.14
(q, J = 3.2 Hz, 1H, H4). 13C NMR (150 MHz, CD3OD): δ 14.5 (CH3),
23.8, 27.0, 29.7 (CH2), 30.4 (CH2, C6), 30.5, 30.70, 30.74, 30.82
(CH2), 31.75 (CH2, C3), 33.1 (CH2), 40.3 (CH, C1), 40.5 (CH, C2),
59.6 (CH, C4), 65.95, 66.06 (COOCH2), 69.5 (CH, C5), 175.7, 176.2
(C_O). HRMS: C32H59ClO5, calcd. m/z [M+H]+ 559.4129, found
559.4136.
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triﬂuoroethylamino)cyclohexane-trans-1,2-dicarboxylate (8)
2,2,2-Triﬂuoroethylamine hydrochloride (0.39 g, 2.8 mmol)
was neutralized by satd. Na2CO3 to pH 7–8 at 0 °C. Bis[cis-8-(2-
octylcyclopropyl)octyl]7-oxabicyclo[4.1.0]heptane-trans-3,4-
dicarboxylate 13d (0.2 g, 0.28mmol) in THF (1mL) was added, and the
mixture was stirred for 7 days at 45 °C. The reaction mixture was con-
centrated on the rotary evaporator, and the crude product was puriﬁed
by column chromatography (silica gel; CHCl3:CH3OH= 100:1) to yield
8 as a colorless oil (0.133 g, 58%). Rf: 0.17 (CHCl3:CH3OH= 150:1). 1H
NMR (600 MHz, CDCl3): δ −0.36 (dt, J = 4.1, 5.3 Hz, 2H, trans-H in
cyclopropyl CH2), 0.54 (dt, J = 4.1, 8.1 Hz, 2H, cis-H in cyclopropyl
CH2), 0.62 (m, 4H, cyclopropyl CH,), 0.86 (t, J = 6.9 Hz, 6H, CH3), 1.11
(m, 4H, octyl CH2), 1.20–1.39 (m, 48H, octyl CH2), 1.49 (ddd, J= 14.0,
9.6, 4.6 Hz, 1H, H6a), 1.61 (m, 4H, octyl CH2), 1.67 (ddd, J = 14.0, 9.4,
4.9 Hz, 1H, H3a), 2.28 (m, 1H, H6e), 2.31 (m, 1H, H3e), 2.57 (dt, J =
3.6, 9.5 Hz, 1H, H5), 3.12 (m, 1H, CH2N), 3.15 (q, J = 4.8 Hz, 1H, H1),
3.22 (q, J = 4.8 Hz, 1H, H2), 3.29 (m, 1H, CH2N), 3.45 (dt, J = 3.8,
9.4 Hz, 1H, H4), 4.07 (m, 4H, COOCH2). 13C NMR (150 MHz, CDCl3): δ
10.9 (CH2, cyclopropyl), 14.1 (CH3), 15.72, 17.76 (CH, cyclopropyl),
22.7, 25.90, 25.95 (CH2), 28.6 (CH2, C6), 28.69, 28.71, 29.2, 29.4, 29.6,
29.7, 30.17, 30.2 (CH2), 31.1 (CH2, C3), 31.9(CH2), 40.2 (CH, C1+C2),
48.2 (NCH2), 59.1 (CH, C5), 65.21, 65.26 (COOCH2), 69.7 (CH, C4),
126.2 (CF3), 173.4, 173.7 (C_O). HRMS: C48H86F3NO5, calcd. m/z
[M+H]+ 814.6536, found 814.6486.
2.2.14. (Z)-Octadec-9-en-1-yl acetate (14)
Acetic anhydride (71 mL, 750 mmol) was added into a stirred solu-
tion of oleyl alcohol (20.14 g, 75 mmol) in pyridine (150 mL) in the
presence of p-dimethylaminopyridine (0.92 g, 7.5mmol) at 0 °C. The re-
action mixture was stirred at room temperature for another 12 h, and
was then poured into ice-water and extracted with ethyl acetate. The
organic layer was washed with 1 N HCl (4 × 100 mL), 6% NaHCO3
(2 × 100 mL) and brine, then dried over Na2SO4, and was concentrated
on the rotary evaporator. The crude product was puriﬁed by column
chromatography (silica gel; hexane:EtOAc = 60:1) to yield 14 as a col-
orless oil (22.52 g, 96%). Rf: 0.38 (hexane:EtOAc = 40:1). 1H NMR
(600 MHz, CDCl3): δ 0.85 (t, J = 6.9 Hz, 3H, CH3), 1.20–1.34 (m, 22H,
CH2), 1.59 (br. quin, J = 7.1 Hz, 2H, CH2), 1.98 (m, 4H, allylic CH2),
2.02 (m, 3H, COCH3), 4.02 (t, J = 6.8 Hz, 2H, OCH2), 5.32 (m, 2H,
HC_CH). 13C NMR (150 MHz, CDCl3): δ 14.1 (CH3), 21.0 (COCH3),
27.16 (allylic CH2), 27.19 (allylic CH2), 28.6, 29.18, 29.21, 29.31, 29.39,
29.51, 29.71, 29.75, 31.9, 32.6 (CH2), 64.6 (OCH2), 129.8 (HC_CH),
130.0 (HC_CH), 171.2 (C_O). HRMS: C20H38O2, calcd. m/z [M+H]+
311.2950, found 311.2919.
2.2.15. cis-8-(2-Octylcyclopropyl)octyl acetate (15)
In a 500 mL three-necked RB ﬂask, a solution of diethyl zinc in hex-
ane (66 mmol, 75.5 mL, 15 w/w%) was added to anhydrous CH2Cl2
(60 mL) at−5 °C under nitrogen followed by the portionwise addition
ofmethylene iodide (10.7mL, 132mmol)with continued stirring at−5 °C.
After 30 min, a solution of (Z)-octadec-9-en-1-yl acetate 14 (7.45 g,
24 mmol) in methylene chloride (40 mL) was added, and the reaction
mixture was stirred for 12 h at−5 °C, and was then allowed to warm
up to room temperature. After stirring for 84 h, the reaction was
quenched with satd. NH4Cl (170 mL), and the aqueous portion was ex-
tractedwith Et2O/CH2Cl2 (5:1; 4 × 70mL). The combined organic layers
were dried over Na2SO4 and concentrated on the rotary evaporator. The
crude product was puriﬁed by column chromatography (silica gel;
hexane:EtOAc = 50:1) to afford 15 as a colorless oil (6.63 g, 85%). Rf:
0.29 (hexane:EtOAc = 40:1). 1H NMR (600 MHz, CDCl3): δ−0.36 (dt,
J = 4.4, 5.3 Hz, 1H, trans-H in cyclopropyl CH2), 0.53 (dt, J = 4.2,
8.2 Hz, 1H, cis-H in cyclopropyl CH2), 0.62 (m, 2H, cyclopropyl CH),
0.86 (t, J = 7.0 Hz, 3H, CH3), 1.11 (m, 2H, CH2), 1.19–1.39 (m, 24H,
CH2), 1.59 (br. quin, J = 7.1 Hz, 2H, CH2), 2.02 (m, 3H, COCH3), 4.02
(t, J = 6.8 Hz, 2H, OCH2). 13C NMR (150 MHz, CDCl3): δ 10.9 (CH2,cyclopropyl), 14.1 (CH3), 15.73, 15.75 (CH, cyclopropyl), 21.0
(COCH3), 22.7, 25.9, 28.59, 28.68, 28.71, 29.26, 29.35, 29.55, 29.68,
31.16, 32.20, 31.9 (CH2), 64.7 (OCH2), 171.2 (C_O). HRMS: C21H40O2,
calcd. m/z [M+H]+ 325.3107, found 325.3100.
2.2.16. cis-8-(2-Octylcyclopropyl)octan-1-ol (16)
8-(2-Octylcyclopropyl)octyl acetate 15 (8.48 g, 26.12 mmol) was
added to a stirred solution of sodium methoxide (25 mM) in methanol
(260 mL). The reaction was stirred at room temperature for 5 h before
addition of Amberlite IR-120 H resin (2 g). After 10 min stirring, the so-
lution was ﬁltered and concentrated on the rotary evaporator. The
crude product was puriﬁed by column chromatography (silica gel;
hexane:EtOAc = 12:1) to afford 16 as a colorless oil (6.79 g, 92%). Rf:
0.25 (hexane:EtOAc = 9:1). 1H NMR (600 MHz, CDCl3): δ−0.36 (dt,
J = 4.3, 5.3 Hz, 1H, trans-H in cyclopropyl CH2), 0.53 (dt, J = 4.1,
8.2 Hz, 1H, cis-H in cyclopropyl CH2), 0.62 (m, 2H, cyclopropyl CH),
0.86 (t, J = 7.0 Hz, 3H, CH3), 1.11 (m, 2H, CH2), 1.20–1.38 (m, 24H,
CH2), 1.54 (br. quin, J = 7.1 Hz, 2H, CH2), 3.62 (t, J = 6.9 Hz, 2H,
OCH2). 13C NMR (150 MHz, CDCl3): δ 10.9 (CH2, cyclopropyl), 14.1
(CH3), 15.75 (CH, cyclopropyl), 22.7, 25.7, 28.7, 29.36, 29.43, 29.59,
29.65, 29.68, 30.2, 31.9, 32.8 (CH2), 63.1 (OCH2). HRMS: C19H38O,
calcd. m/z [M+H]+ 283.3001, found 283.2963.
2.3. NMR analysis of the pH-dependent conformational equilibrium of am-
phiphiles 1–8
The spin–spin coupling constants between several pairs of vicinal pro-
tons attached to the cyclohexane moiety are strongly conformation-
dependent, which allowed the assignment of a predominant conforma-
tion and the estimation of a position of the conformational equilibrium
as described previously [21–24,31,32]. To characterize the pH-induced
change of conformational equilibrium, a TACH-lipid was dissolved
in CD3OD (0.02–0.03 M), and the changes of its 1H NMR spectrum
(600 MHz) were monitored during titration of the solution with
d-triﬂuoroacetic acid (d-TFA) and with a base: 1,8-diazabicyclo
[5.4.0]undec-7-ene (DBU). Acid or base was dissolved in CD3OD
(1 M) and added to the TACH-lipid solution in a NMR tube
(0.6 mL) in small portions (1–5 μL). After every addition the solu-
tion was thoroughly mixed by gentle shaking, and its apparent pH
(pD) was measured using a micro-combination pH electrode for
NMR cells (9826BN, Thermo Scientiﬁc). Shaking and pD-measurement
were repeated 3–4 times until the reading became stable. The 1H
NMR spectrum was then recorded, followed by re-measurement of
the pD to ensure that the original and ﬁnal values matched within
0.05 units.
2.4. Preparation and characterization of cationic liposomes and lipoplexes
[33]
The cationic lipid DOTAP and a helper lipid (1:1 molar ratio) were
dissolved in dichloromethane in a Pyrex glass test tube. Dichlorometh-
ane was removed by rotary evaporation at room temperature (RT) to
form a lipid ﬁlm at the bottom of the tube. Residual dichloromethane
was removed under high vacuumovernight. The lipid ﬁlmwas then hy-
drated with a pH 7.4 buffer (10mMHEPES, 20 mMNaCl) into a 0.3mM
total lipid suspension by 10 min agitation with a bench top vortex ma-
chine at RT. The suspension was extruded 11 times through a 0.2-μm
polycarbonate membrane (Nucleopore, Pleasanton, CA, USA) with a
hand-held extrusion device (Avanti Polar Lipids, Alabaster, AL, USA) to
yield a cationic liposomepreparation. Prior to transfection, an equal vol-
ume of plasmid DNA solution (10 μg DNA/mL, pH 7.4, 10 mM HEPES,
20mMNaCl)was addeddropwise to the liposomepreparation followed
by gentle agitationwith a vortex to form a lipoplex suspension at N/P=
5/1, where N/P is deﬁned as the molar ratio of the quaternary ammoni-
um of DOTAP and the phosphate of DNA. Aliquots of the resultant
lipoplex suspension (5 μg DNA/mL, N/P = 5/1) was further diluted to
3119Y. Zheng et al. / Biochimica et Biophysica Acta 1848 (2015) 3113–31251.67 μg DNA/mL and to 0.50 μg DNA/mL with a pH 7.4 buffer (10 mM
HEPES, 20 mM NaCl). The three lipoplex suspensions were then used
to study dose-dependent gene transfection (Section 3.5) and cytotoxic-
ity (Section 3.6).
The hydrodynamic diameter and the ζ-potential of the cationic li-
posomes and lipoplexes were measured with a Malvern Zeta 3000
dynamic light scattering instrument (Malvern Instruments Ltd.,
Worcestershire, UK), using the automatic algorithm mode.
2.5. Gene transfection in cultured cells
The gene transfection procedure is similar to a reportedmethod [33,
34]. B16F1 cells (a mouse melanoma cell line, CRL-6323) and HeLa cells
(a human cervical adenocarcinoma cell line, CCL-2) were cultured in
DMEMcontaining 10% FBS, 4mM L-glutamine, 1500mg/L sodiumbicar-
bonate and antibiotics (100 IU/mL penicillin and 100 μg/mL streptomy-
cin) according to ATCC recommendations. Twenty-four hours before
gene transfection, when cells were at approximately 80–90% conﬂu-
ence, the cells were seeded onto 96-well plates (2 × 104 B16F1 cells/
well and 1.6 × 104 HeLa cells/well; cell counting performed with a he-
macytometer; 100 μL complete growth medium per well) and cultured
overnight at 37 °C under a humidiﬁed atmosphere containing 5% CO2 to
reach approximately 70% conﬂuence before transfection.
To start transfection, the complete growth medium was aspirated
and the cells were washed with the transfection medium (100 μL/
well) and then supplemented with 80 μL/well antibiotics-free transfec-
tion medium either with or without serum. For each lipoplex compris-
ing different helper lipids, three doses (100 ng, 33 ng, and 10 ng DNA/
well) were applied by pipetting 20 μL freshly prepared lipoplexes at dif-
ferent concentrations (5 μg, 1.67 μg, and 0.50 μg DNA/mL, respectively,
N/P = 5/1) to the cells followed by mild agitation of the 96-well plate.
After incubation at 37 °C, 5% CO2 for 6 h, the transfectionmediawere as-
pirated, and the cells were washed twice with complete growth medi-
um (100 μL/well). The cells were then supplemented with complete
growth medium (100 μL/well) and cultured for an additional 18 h
before the assessment of reporter gene expression.
2.6. Reporter gene expression assay
The pCMV-GLuc plasmid DNA, a mammalian expression vector that
encodes the Gaussia Luciferase (GLuc) as a reporter under the control of
the Cytomegalovirus (CMV) promoter, was complexed with cationic li-
posomes for gene transfection into cells. Gaussia Luciferase (GLuc,
19 kDa) was originally isolated from the marine organism Gaussia
princeps. The enzyme catalyzes the oxidation of coelenterazine and
emits light (475 nm) as a by-product [35,36].
The activity of Gaussia luciferase encoded by the reporter gene was
assessed with a BioLux® Gaussia Luciferase (GLuc) Assay Kit following
a protocol based on the manufacturer's recommendations with slight
modiﬁcation. Brieﬂy, 20 μL/well culture supernatant was transferred
into a Corning 96-well white polypropylene assay plate. The luciferase
activity was measured at 480 nm using a multimode automated micro-
plate reader (Tristar, Brethold Technology, Austria) after the injection of
40 μL substrate/well and 2 s shaking. Luciferase activity is presented as
relative light units (RLU) normalized by total cellular protein per well
[33].
2.7. Cytotoxicity
Cytotoxicity of the gene transfection was monitored by quantifying
the decrease of total cellular protein [33] with a Micro BCA Protein
Assay Kit following the manufacturer's recommendations. Brieﬂy, after
luciferase activity assay, the complete growth medium was aspirated
and the cells were washed twice with PBS (100 μL/well) and then
lysedwith theM-PER®Reagent (20 μL/well). To eachwell 150 μLWork-
ing Reagent (prepared from the Micro BCA Protein Assay Kit followingthe manufacturer's manual) was then added and followed by incuba-
tion at 37 °C for 3 h. After cooling to RT, the absorbance of the solution
at 560 nm was measured using a multimode automated microplate
reader (Tristar, Brethold Technology, Austria).
3. Results and discussion
3.1. Design of TACH lipids
Seven novel amphiphiles (2–8) have been designed and investigat-
ed as potential helper lipids for lipoplexes together with the previously
reported TACH-lipid 1 (Fig. 1) [21–24]. All the lipids (1–8) share the
common structural features of a trans-2-aminocyclohexanol (TACH)
moiety as the polar headgroup and two trans-alkoxycarbonyl groups
at the 4- and 5-positions of the cyclohexane ring as the lipid tails.
Such structural features were designed to achieve protonation-
triggered conformational switch of the lipid tails (Scheme 1) [21–24].
Lipids 1–4 form a subgroup among the TACH-lipids in that they carry
a common morpholine group as the amino group of the TACH moiety
but different lipid tails. Our prior NMR studies on lipid 1 showed that
the protonatedmorpholine had an apparent pKa around 4.7 in deuterat-
ed methanol [21–24], which is relevant to the mildly acidic pH of the
endosomal/lysosomal compartments [37]. The lipid tails in 1–4 include
the relatively short, linear C12 chains in lipid 1, the longer, linear, satu-
rated C16 chains in lipid 2, the branched C16 chains in lipid 3, and the
long C19 chains with a kink from a cyclopropyl group in lipid 4. These
diverse lipid tails are designed to modulate the ﬂuidity of their corre-
sponding lipid membranes in lipoplexes [23]. Longer hydrocarbon
chains in the lipid tails (e.g. C16 in 2) are introduced to increase rigidity
(to decrease ﬂuidity) of the lipid membrane due to their van der Waals
attraction. This may increase the stability of the corresponding
lipoplexes in serum [38] which would enhance gene delivery in vivo
after i.v. injection [39,40]. Conversely, the lipid tails of 3 and 4 are de-
signed to render higher ﬂuidity of the lipid bilayers in lipoplexes [38,
40], which would enhance the lipoplex–biomembrane interaction and
biomembrane destabilization to transfer more DNA of the lipoplexes
from the endosome/lysosomes into the cytosol and consequently into
the nucleus for higher transgene expression [41]. Themost commonhy-
drocarbon chain ofﬂuidic lipids for gene delivery is the C18 oleoyl group
that has a kink at the cis-carbon–carbon double bond (e.g. DOPE, DOTAP
and DOTMA) [38–45]. However, the synthesis of TACH-lipids with un-
saturated hydrocarbon chains would be a challenge because the cis-
double bondwould reactwith epoxidizing reagents alongwith the dou-
ble bond in the cyclohexene ring of the intermediates 12 (Scheme 2).
We protected the double bond against oxidation by transformation
into a cis-cyclopropyl group (Scheme 3) as a bioisosteric alternative
for the introduction of a kink in the hydrocarbon chains (for TACH-
lipids 4 and 8 in Fig. 1). The methylenation would not signiﬁcantly
change the lipid transition temperature (Tc) nor the ﬂuidity of the
corresponding lipid membrane [42,43]. Phospholipids bearing a
cyclopropylated hydrocarbon chain have already been discovered in na-
ture such as an Escherichia coli phosphatidylglycerol (PG) [44]. The ad-
vantage here is that the cyclopropyl ring on the lipid tail is chemically
stable during the formation (Diels–Alder cycloaddition) and the subse-
quent epoxidation of the cyclohexene intermediate 12 in the synthetic
scheme.
Lipids 5–7 carry the same relatively short, linear C12 chains as 1, but
various amino groups of different basicity in the headgroup (see Fig. 1),
including the ethanolamine group in lipid 5, the methoxyethylamine
group in lipid 6, and the 2,2,2-triﬂuoroethylamine group in lipid 7.
Our previous studies have shown that the pH-range of conformational
ﬂip performed by the TACH-lipids depends on the basicity of their
amino headgroups [24]. Strongly basic headgroups of TACH-lipids may
be protonated to ﬂip the conformation and perturb the lipid bilayer
even at physiological pH 7.4 whereas lipoplexes containing TACH-
lipids of lower basicity could be triggered selectively at acidic sites
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vestigation on various TACH-lipids of different basicity would allow us
to control the pH range of their conformational ﬂip, thus programming
the pH-sensitivity of their lipoplexes for optimal gene delivery
efﬁciency.
Lipids 9 and 10 (Fig. 1) were also investigated as structural analogs
of TACH-lipids that do not perform protonation-triggered conforma-
tional switch. Lipid 9 is a stereoisomer of TACH-lipid 1 that has two
dodecyloxycarbonyl groups in the cis-conﬁguration. The predominant
conformation of 9 is alwayswith three substituents in the equatorial po-
sition regardless of pH [21,22]. Lipid 10 is an analog of TACH-lipids 1 and
5–7 with the amino group replaced by a non-ionizable chlorine atom.
3.2. Synthesis
The general synthesis of the novel lipids 2–9 was based on the pre-
viously reported synthesis of 1 [21,22] with modiﬁcations (Scheme 2).
Fumaryl chloride was reﬂuxed with appropriate alcohols in dry toluene
to generate the corresponding dialkyl fumarates 11, which were then
cyclized into cyclohexenes 12 with butadiene sulfone in the presence
of hydroquinone as a catalyst. The alkenes 12 were oxidized by m-
CPBA to form epoxides 13, which were then cleaved with an appropri-
ate amine (2–8) to yield the target lipids. The chlorohydrin 10 was
isolated as a byproduct in synthesis of the lipid 7.
3.3. pH-triggered conformational ﬂip of amphiphiles 1–8
Weexamined the conformational chair–chairﬂip of the cyclohexane
ring in TACH-lipids 1–8 (Scheme 4) in solution by 1H NMR
(600 MHz) as described previously for structurally similar trans-2-
aminocyclohexanols [21–24,31,32]. The vicinal coupling constants
3JHH between several protons attached to the cyclohexane moiety
are strongly conformation-dependent, which allows an assignment
of a predominant conformation and an estimation of the position of
conformational equilibrium [46].
The conformer populations (nA, nB) in the fast equilibrium
[A]⇄ [B+ BH+] (Scheme 4) were calculated from an averaged signal
width (W = ΣJHH) measured as the distance between terminal peaks
of a multiplet in the 1H NMR spectrum: Wobserved = WA·nA + WB·nB
[46] (Table 1).We usedmainly the signal of H4 (geminal to the hydroxy
group, Scheme 1),whichwas usually better resolved and located in a re-
gion apart from other signals. The limiting parameterWB was assumed
to equalWBH+, that is the value observed in the presence of excess acid
(ΣJHH = 25.6 Hz for 1, 25.5 Hz for 2 and 4, 25.3 Hz for 3 and 7, and
24.6 Hz for 6; Table 1), and the parameterWA was estimated as 9.0 Hz
from reported data [31,32] for the related conformationally biased
(amino)cyclohexanols. The share of the conformer B (nB) includes
both the protonated form B·H+ (apparently the major one in excess
acid) and the non-protonated form B. The coupling constants for other
protons of the cycle, mainly H1, H2, and H5, were used to conﬁrm the
conformational assignment.
In accordance with the previous observations for various trans-2-
aminocyclohexanols [21–24,31,32], all the tested lipids strongly prefer
the conformation B (Scheme 4, Table 1) in a nonpolar solvent (CDCl3)
because of the stabilizing intramolecular hydrogen bond OH⋯N. In
strongly polar d4-methanol, which is both a hydrogen bond donor andScheme 4. Protonation-induced chair–chair ﬂip and cacceptor, this intramolecular hydrogen bond is effectively replaced by
interactions with the solvent, and compounds 1–4 and 6–7 initially
adopt predominantly conformation A with the bulky ester groups
(lipid tails) in the equatorial position. Under all the studied conditions,
the 1H NMR and conformational parameters were practically identical
between compounds 1–4 that carry the same morpholino group
(Table 1). Thus, the elongation, branching, or cyclopropylation of the
hydrocarbon chains did not substantially inﬂuence the conformation
of the polar heads in the tested TACH-lipids. On the other hand, the ini-
tial conformational equilibrium varied with the structure of the amino
headgroup (Table 1). It is more biased toward the conformation B in
CDCl3 for TACH-lipids 1–4 with morpholino group (~96%), which may
be partially attributed to a larger size and conformational energy of
this secondary amino group versus the primary methoxyethylamino
and triﬂuoroethylamino groups in 6 and 7 respectively [47]. In highly
polar CD3OD, the variation of conformational bias toward form A of
TACH-lipids with the structure of amino headgroup is also noticeable.
The conformations of trans-2-aminocyclohexanols are determined by
a complex structure-dependent interplay of steric and polar interac-
tions between the amino- and hydroxy groups and by the geometrical
requirements of the intramolecular hydrogen bond in addition to the in-
teractions with the solvent [32].
To characterize the acid-induced shift of the conformational equilib-
rium, the changes of 1HNMR spectraweremonitored during titration of
the diluted CD3OD solutions of 1–4, 6 and 7 with d-triﬂuoroacetic acid
(d-TFA). The observation of well-resolved multiplets in the course
of acidiﬁcation attests to high rates of both conformational and
acid–base equilibria on the NMR time scale. During the incremental
addition of acid, the signal width of H4 and H5 in the spectra of test-
ed lipids in CD3OD increased signiﬁcantly (Table 1; Fig. 2a), indicat-
ing a strong protonation-induced shift of the conformational
equilibrium from A (~75% for 1–4, ~61% for 6, and ~84% for 7 in orig-
inal solutions) to BD+ (~100% in excess acid). The originally well-
resolved signals of H1 and H2 became narrow and unresolved, and
both shifted downﬁeld upon the drop of pD (Table 1, Fig. 2b). Be-
cause equatorial protons typically give a signal at lower ﬁeld than
the otherwise equivalent axial protons, this observation attests to
an axial-to-equatorial switch of H1 and H2, and thus to the
equatorial-to-axial switch of the ester groups (Scheme 4) Using
the difference in ΔGB–A values in methanol solution before and
after addition of acid (Table 1), we estimated the impact of this con-
formational pH-trigger to be ≥12 kJ/mol for 1–4, ≥11 kJ/mol for 6,
and ≥14 kJ/mol for 7, which is close to the estimations for other
trans-2-aminocyclohexanols [21–24,31,32].
We observed previously that several TACH-lipids [21–24] did not
change their relative conformer population gradually over the
whole course of titration, but did so only within a narrow range of
acidity. The current NMR titration curves for both the signal widths
(Fig. 2a) and the chemical shifts (Fig. 2b) demonstrate such a dra-
matic conformational switch between pD 6.0–4.0 for 1–3, between
pD 6.5–4.0 for 4, between pD 8.0–6.0 for 6, and between pD 4.0–
1.0 for 7. The relative position of these transitional areas matches
the expected higher basicity of the secondary amine 6 than the ter-
tiary amines 1–4, and an expected lower basicity of 7 than 6 and
1–4 due to the electron-withdrawing triﬂuoroethyl substituent on
the amine group of 7.onformational switch of lipid tails in TACH-lipids.
Table 1
1H NMR spectroscopic data and conformational parameters for TACH-lipids.a
Compound, solvent, acid
H4 H5 H2 H1 nB + nBH+ ΔGB–A
δ W, Hz δ W, Hz δ W, Hz δ W, Hz % kJ/mol
1
CDCl3 3.50 24.8 2.30 25.2 3.30 –d 3.30 –d 95 −7.4
CD3OD 3.99 13.2 2.23 13.8 3.08 23.3 2.98 22.5 25 2.7
+TFAb 3.89 25.6e 3.26 26.5 3.32 –d 3.41 –c ~100 b−10
2
CDCl3 3.47 24.9 2.27 25.1 3.27 9.1c,d 3.27 9.1c,d 97 −8.2
CD3OD 4.00 13.3 2.23 13.7 3.08 23.4 2.98 22.6 26 2.6
+TFAb 3.90 25.5e 3.26 26.5 3.32 –d 3.41 –c ~100 b−10
3
CDCl3 3.46 ~24c 2.27 –c,d 3.29 9.3c,d 3.29 9.3c,d N92 b−6
CD3OD ~4.0 –d 2.24 13.5 3.09 23.4 2.99 22.6 ~25 2.6
+TFAb 3.92 25.3e ~3.3 –d 3.32 –d 3.41 –c ~100 b−10
4
CDCl3 3.47 24.9 2.27 25.3 3.28 9.2c,d 3.28 9.2c,d 96 −8.0
CD3OD 4.00 13.4 2.25 13.7 3.09 23.2 2.99 22.4 26 2.6
+TFAb 3.90 25.5e 3.26 26.6 3.32 –d 3.41 –c ~100 b−10
6
CDCl3 3.44 ~20d 2.45 20.5 3.21 14.8 3.16 14.3 ~70 −2.1
CD3OD 3.67 15.2 2.63 15.5 3.10 20.8 3.03 20.6 39 1.1
+TFAb 3.73 24.6e 3.16 25.5 ~3.3 –d 3.33 –d ~100 b−10
7
CDCl3 3.45 20.3 2.57 20.2 3.22 14.5 3.14 14.4d 69 −2.0
CD3OD 3.74 11.7 2.79 11.7 3.03 24.9d 2.99 24.8d 16 4.1
+TFAb 3.81 25.3e 3.33 26.5d ~3.3 –d 3.36 –c,d ~100 b−10
a 600 MHz, 21 °C for 1–3 and 6, 7, 33 °C for 4, 0.01–0.03 M.
b d-TFA was added in large excess to the CD3OD solution.
c A poorly resolved signal width at 1/2 of its height or an unresolved signal.
d Substantially or completely overlapped with other signals.
e Used asWB.
Fig. 2. (a) Change of the signal width (W= ΣJHH) for the proton H4, and (b) change of the
chemical shift for the proton H1 in 1H NMR due to the conformational switch of TACH-
lipids 1 (dark green ♦), 2 (purple ○), 3 (pink □), 4 (light green▲), 6 (blue●), and 7 (or-
ange ■) in CD3OD solution caused by titration with d-TFA.
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somes and lipoplexes containing TACH-based helper lipids
The TACH-lipids were then formulated into lipoplexes containing
the well-studied cationic lipid DOTAP. The physicochemical properties
of the lipoplexes were characterized in comparison to corresponding
lipoplexes consisting of the well-established helper lipids DOPE or cho-
lesterol. We elected to prepare cationic liposomes and the correspond-
ing lipoplexes that carry the cationic lipid DOTAP and the TACH helper
lipid in 1/1M ratio for the following two reasons. First, our prior studies
showed that 50 mol% of TACH-lipids in liposome membranes rendered
themaximumpH-sensitive leakage of the liposomeswithout jeopardiz-
ing their colloidal stability at pH 7.4 [22–24]. Second, such 1/1 molar
ratio matches those in most reported lipoplexes that carry a cationic
lipid and a helper lipid so that our gene transfection (Section 3.5) and
toxicity studies (Sections 3.6) can bemore closely compared to prior in-
vestigations [48,49]. Thus the lipid ﬁlms of the cationic lipid DOTAP and
a helper lipid (1:1 molar ratio) were hydrated by agitation in a pH 7.4
buffer (10 mMHEPES, 20mMNaCl) into a 0.3 mM (total lipid) suspen-
sion. The suspension was extruded 11 times through a polycarbonate
membrane with pores 200 nm in diameter to yield a homogeneous cat-
ionic liposome preparation. The cationic liposomes were then mixed
with a plasmid DNA solution to form a lipoplex suspension at N/P =
5/1, where N/P is deﬁned as the molar ratio of the quaternary ammoni-
um of DOTAP and the phosphate of DNA. All the prepared lipoplexes
carried excess positive surface charges as indicated by the positive ζ-
potential values (Table 2). Generally all the lipoplexes decreased in ζ-
potential values and increased in size as compared to the corresponding
cationic liposomes, which is consistent with other studies of cationic
lipoplex-mediated transfection [33,50]. The hydrodynamic diameter of
the lipoplexes ranges between 190 and 380 nm. The size of
lipoplexes containing TACH-lipids was overall inversely correlated
with the ζ-potential values, most probably because the strong elec-
trostatic repulsion between highly cationic lipoplexes (1–3, and 6)
would hinder their aggregation and fusion into larger particles
Table 2
Colloidal properties of cationic liposomes and lipoplexes containing TACH-lipids.a
X Liposomes (DOTAP/X)b Lipoplexes (DOTAP/X/DNA)c
Diameter
(nm)
Polydispersity index ζ-Potential
(mV)
Diameter
(nm)
Polydispersity index ζ-Potential
(mV)
DOPE 171.2 0.202 28.6 218.0 0.088 13.8
Cholesterol 206.8 0.133 38.4 255.8 0.055 27.4
1 197.9 0.355 40.8 216.7 0.178 25.3
2 194.0 0.398 42.7 242.7 0.066 36.3
3 178.6 0.232 32.2 268.3 0.096 32.2
4 141.9 0.203 19.2 251.4 0.285 9.98
5 167.1 0.239 18.2 193.5 0.190 9.83
6 154.7 0.331 34.6 179.0 0.183 33.0
7 147.2 0.288 17.2 338.9 0.742 5.73
8 155.0 0.270 21.5 374.4 0.685 11.2
9 194.9 0.389 7.56 354.8 0.815 0.915
10 164.9 0.273 12.2 255.0 0.661 1.35
a Samples were measured in 10 mM HEPES buffer, pH 7.4, and three measurements were performed for each sample. Hydrodynamic diameter and ζ-potential are reported as mean
with less than 10 nm and 5 mV variation, respectively.
b DOTAP and helper lipid are in 1:1 molar ratio.
c 5 μg DNA/mL, N/P = 5/1.
Fig. 3. Luciferase gene expression of TACH-based lipoplexes (a) in B16F1 cells in serum-free medium, (b) in HeLa cells in serum-free medium, (c) in B16F1 cells in serum-containing me-
dium and (d) in HeLa cells in serum-containingmedium. Each lipoplex contains 50 mol% DOTAP and 50mol% helper lipid; N/P= 5/1. DOPE and cholesterol lipoplexes are pH-insensitive
controls. TACHanalogs 9 and 10 lipoplexes are controlswithout the conformational switch. The lipoplexeswere given in three doses: 10 ngDNA/well (dotted bars); 33 ngDNA/well (black
bars) and 100 ng DNA/well (striated bars). Striated bar on the right: DNA solution in buffer control; blank bar on the right: buffer control.
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served after the lipoplex preparations were stored at room tempera-
ture for several hours.
3.5. Luciferase gene transfection by lipoplexes comprising TACH-based
helper lipids
In order to test the capacity of TACH lipids in enhancing gene trans-
fection, B16F1 (mouse melanoma) [52] and HeLa (human cervical can-
cer) cells [53] in culture were treated with lipoplexes (DOTAP/TACH/
DNA, N/P = 5/1) consisting of DOTAP [28,29] as the cationic lipid and
various TACH-based lipids 1–8 as the helper lipid. In comparison, the re-
ported lipoplexes DOTAP/DOPE/DNA and DOTAP/cholesterol/DNA (N/
P= 5/1) were administered as pH-insensitive controls [33,54]. Further-
more, lipoplexes DOTAP/9/DNA and DOTAP/10/DNA (N/P = 5/1),
which contained TACH analogs (9) [21,22] or (10) that do not switch
conformationwere also characterized in an effort to decipher the contri-
bution of conformation switch to the gene transfection by TACH lipids.
Overall, TACH-based lipoplexes exhibited remarkably higher gene
transfection than the common pH-insensitive lipoplexes DOTAP/
DOPE/DNA and DOTAP/cholesterol/DNA (N/P = 5/1). Under all variousFig. 4. Luciferase gene cytotoxicity (shown by the decrease of cellular proteins) of TACH-lipid-
medium, (c) in B16F1 cells in serum-containing medium and (d) in HeLa cells in serum-cont
5/1. DOPE and cholesterol lipoplexes are pH-insensitive controls. TACH analogs 9 and 10 lip
doses: 10 ng DNA/well (dotted bars); 33 ng DNA/well (black bars) and 100 ng DNA/well (s
right: buffer control.conditions of the transfection (Fig. 3) including three different lipoplex
dosages (10, 33 and 100 ng DNA/well), two different cell lines, and
whether or not the medium contains serum, two or more of the eight
total lipoplexes comprising TACH lipids 1–8 demonstrated a few fold
to more than a hundred fold higher gene transfection than the
DOTAP/DOPE/DNA and DOTAP/cholesterol/DNA lipoplexes. Such
broad-based improvement of gene transfection by the TACH-based
lipoplexes validates the TACH-lipids as a new class of helper lipids to en-
hance the efﬁciency of gene delivery by lipoplexes.
Compared to analogous lipoplexes without the conformational
switch (DOTAP/9/DNA and DOTAP/10/DNA), the majority of the
TACH-based lipoplexes consisting of 1–8mediated higher gene trans-
fection at low (10 ngDNA/well) andmedium(33 ngDNA/well) lipoplex
dosages, suggesting signiﬁcant contribution of conformational switch to
the gene delivery efﬁciency of TACH-based lipoplexes at such dosages.
However, at a high dose of 100 ng DNA/well, the non-switchable
lipoplexes DOTAP/9/DNA and DOTAP/10/DNA mediated similar trans-
gene expression compared tomost of the TACH-based lipoplexes except
for DOTAP/7/DNA and DOTAP/8/DNA. Such partial loss of advantage in
the conformationally switchable lipoplexes at high dosage suggest
that other physicochemical properties of the lipids/lipoplexes underbased lipoplexes (a) in B16F1 cells in serum-free medium, (b) in HeLa cells in serum-free
aining medium. Each lipoplex contains 50 mol% DOTAP and 50 mol% helper lipid; N/P =
oplexes are controls without conformational switch. The lipoplexes were given in three
triated bars). Striated bar on the right: DNA solution in buffer control; blank bar on the
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membrane charge density [56] may also contribute to their gene
delivery efﬁciency, especially at high lipoplex dosage. Neverthe-
less, given the considerable cytotoxicity of the lipoplexes at
100 ng DNA/well dosage (Fig. 4), the low (10 ng DNA/well) and
medium (33 ng DNA/well) dosages would be more relevant to
gene therapy, where the TACH-based lipoplexes with a conforma-
tional switch can serve as an enhanced and yet safe gene delivery
system.
As commonly reported for lipoplexes, serum, which is a substan-
tial barrier for gene delivery in vivo [57,58] decreased the overall
level of transgene expression in our studies as well. However, com-
pared to DOPE- and cholesterol-based lipoplexes under the same ex-
perimental condition (either with or without serum), the TACH
lipoplexes consistently mediated higher gene transfection, suggest-
ing that TACH lipoplexes would serve as an improved gene delivery
system in both cultured cells and in animals/humans. Furthermore,
in the presence of serum, DOTAP/7/DNA lipoplex mediated similar
levels of gene transfection at high dosage to those without serum,
suggesting that TACH-based lipoplexes could be further optimized
to achieve in vivo gene delivery at a level comparable to that in cul-
tured cells.
The ranking in gene transfection efﬁciency by lipoplexes of different
TACH lipids depends on both the lipid structure and the lipoplex dosage.
At a low lipoplex dose of 10 ng DNA/well, lipid 6, which carries a more
basic methoxyethyl amine type headgroup (apparent pKa ~ 7 in meth-
anol, Fig. 2) and a dilauryl (C12) lipid tail represented a leading lipid
that mediated the highest gene transfection in B16F1 cells without
serum, the second highest gene transfection in HeLa cells without
serum, the third highest gene transfection in B16F1 cells with serum,
and the highest gene transfection in HeLa cells with serum. However,
lipids 7 and 8 with a less basic (apparent pKa ~ 3 in methanol, Fig. 2)
and less polar triﬂuoroethylamino type headgroup stood out as the
leading lipids at the medium (33 ng DNA/well) and high (100 ng
DNA/well) lipoplex dosages in both B16F1 and HeLa cell lines both
with and without serum in transfection media. Such dose-dependent
ranking of gene delivery efﬁciency is somewhat intriguing but suggests
that multiple factors and even multiple mechanisms may contribute to
the gene delivery process [9,59]. One more speciﬁc possibility would be
that, at the lowDNA dosage, early endosome destabilization upon small
pH decrease by lipoplexes containing a TACH lipid of higher pKa would
preserve and transfermaximumDNA from the endosome to the cytosol
whereas at medium and high DNA dosages, lipoplexes containing a
TACH lipid of lower pKa would protect at least part of the complexed
DNA as it is processed to the more acidic late endosome/lysosome
followed by late endosome/lysosome destabilization to release the
cargo gene closer to the nucleus for higher nuclear incorporation and
expression.
The high gene transfection mediated by lipids 7 and 8 can also
be attributed to the relatively low polarity and thus smaller hydro-
dynamic radius of their triﬂuoroethylated headgroup. The small
hydrodynamic radius of a lipid headgroup is known to yield a
more negative curvature of the lipid and thus to facilitate the fu-
sion between the corresponding lipoplexes and biomembranes
[16,60] In comparison between the two triﬂuoroethylated TACH
lipids, lipid 8 containing an unsaturated dioleyl lipid tail mediated
higher gene transfection, especially at the high DNA dosage. This is
consistent with the literature on lipoplexes for gene delivery,
where the unsaturated dioleyl lipid tail provides both high ﬂuidity
[55] and more negative curvature to the lipids, both facilitating the
fusion between the corresponding lipoplex and the biomembranes.
Overall, the genedelivery by TACH-based lipoplexes apparently ben-
eﬁts not only from the pH-triggered conformational switch of the TACH
lipids, but also from certain physicochemical characteristics of the lipids
that are known to enhance lipoplex-mediated gene transfection in
general.3.6. Cytotoxicity study of lipoplexes comprising TACH-based helper lipids
Fig. 4 shows that as B16F1 and HeLa cells were treated with increas-
ing dosage of lipoplexes, their total cellular protein decreased, indicat-
ing dosage-dependent toxicities of the lipoplexes in both B16F1 and
HeLa cells. In general, the same dosage of the lipoplexes inﬂicted
lower toxicity to cells in serum-containing media than those in serum-
free media, probably because serum proteins can coat cationic
lipoplexes to decrease their interaction with the cells [58]. Another
probable reason for lower toxicity in cells with serum is that such cells
grow faster (higher total cellular protein in untreated cells, Fig. 4) so
that each cell with serum is exposed to less lipoplex than each corre-
sponding cell in the absence of serum. In the B16F1 cell lines, the
DOTAP/8/DNA lipoplex mediated 100-fold higher transgene expression
than the pH-insensitive lipoplexes containing DOPE at a high dosage
(100 ng DNA/well) while the total cellular protein decreased only by
25%, indicating that its improved transgene expression in terms of rela-
tiveﬂuorescent light units normalized by cellular proteinwas not attrib-
uted to the increased toxicity. Compared to the cells treated with
DOTAP/DOPE/DNA and DOTAP/Cholesterol/DNA lipoplexes, the vast
majority of the lipoplexes comprising TACH-lipids showed similar
cytotoxity except for those consisting of 6 or 7 in HeLa cells, suggesting
that the TACH-based lipoplexes can be used as safe gene delivery sys-
tems both in the presence and absence of serum.
4. Conclusions
A variety of TACH-lipids were incorporated as helper lipids into
lipoplexes comprising the cationic lipid DOTAP, and their ability to im-
prove gene transfection were tested in two cell lines (B16F1 and
HeLa) in both serum-free and serum-containing transfection media.
Compared to the lipoplexes comprising the conventional helper lipids
DOPE or cholesterol, most tested lipoplexes demonstrated equal or bet-
ter transfection efﬁciencies, validating the TACH-lipids as a novel type of
helper lipids for efﬁcient gene transfection. However, the enhancement
of gene transfection by TACH lipids cannot be explained solely by the
protonation-induced conformational ﬂip of the TACH-amphiphiles.
Other structural features of TACH-lipids that improve compaction of
DNA in lipoplex or help DNA penetrate the endosomal membrane
may also contribute to the improved gene transfection. The relatively
low cytotoxicity of the TACH lipoplexes in both cell lines, especially in
serum-containing media suggests that TACH-lipids could serve as safe
helper lipids for gene delivery.
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